EASL Podcasts
By European Association for the Study of the Liver
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 84
Description
The EASL Podcast collection includes educational podcasts and audio versions of digital EASL offerings. The ASK EASL Podcasts: Ongoing series of educational podcasts. EASL Studio: Your weekly hepatology broadcast news.
| Episode | Date |
|---|---|
|
EASL Studio Podcast: YI Choice: Citizen science: Societal engagement in hepatology
|
Mar 28, 2024 |
|
EASL Studio Podcast: Therapy hierarchy in HCC: A new kid on the block
|
Mar 21, 2024 |
|
EASL Studio Podcast: Is there a role for measuring blood ammonia in patients with cirrhosis?
|
Mar 14, 2024 |
|
EASL Studio Podcast: The impact of policy measure in preventing liver diseases: The Hepahealth II study
|
Mar 07, 2024 |
|
EASL Studio Podcast: Alpha-1-antitrypsin deficiency (AATD): A poster child for genetic therapy
|
Feb 29, 2024 |
|
EASL Studio Podcast: JHEP Live: Should the compensated advanced chronic liver disease (cACLD) concept replace cirrhosis?
|
Feb 22, 2024 |
|
EASL Studio Podcast: World Cholangiocarcinoma Day: Highlighting guidelines and exploring the horizon beyond
|
Feb 15, 2024 |
|
EASL Studio Podcast: How to stop recurrent bleeding due to small-intestinal angiodysplasia?
|
Feb 08, 2024 |
|
EASL Studio Podcast: Do we solve MASLD by treating obesity?
|
Jan 25, 2024 |
|
EASL Studio Podcast: EASL Studio’s holiday reflection: A look back to leap forward
|
Dec 21, 2023 |
|
EASL Studio Podcast: Hepatic encephalopathy: Underdiagnosed and underestimated
|
Dec 14, 2023 |
|
EASL Studio Podcast: Basics in decision-making for liver cancer treatment
|
Dec 07, 2023 |
|
EASL Studio Podcast: PSC and AIH overlap syndrome: does it actually exist?
|
Nov 30, 2023 |
|
EASL Studio Podcast: The window hypothesis again, or just a closed window?
|
Nov 23, 2023 |
|
EASL Studio Podcast: Why should diabetologists care about the liver?
|
Nov 16, 2023 |
|
EASL Studio Podcast: Alcohol and the new nomenclature – A game-changer?
|
Nov 09, 2023 |
|
JHEP Live: Hepatitis delta’s latest debate: Updates straight from EASL’s slate
|
Nov 02, 2023 |
|
EASL Studio Podcast: Why bother with diet and exercise when an injection will suffice?
|
Oct 19, 2023 |
|
EASL Studio Podcast: YI Choice: When stars fade: The untold story of burnout in academia
|
Oct 12, 2023 |
|
EASL Studio Podcast: JHEP Live: The new nomenclature for SLD: A multidisciplinary evaluation and approach
|
Oct 05, 2023 |
|
EASL Studio Podcast: Highlights from the EASL SLD Summit 2023
|
Sep 27, 2023 |
|
EASL Studio Podcast: Zoonotic Hepatitis E – What’s hot in 2023?
|
Sep 21, 2023 |
|
EASL Studio Podcast: Are 30% of the global population sick? A critical view on Steatotic Liver Disease and care pathways
|
Sep 14, 2023 |
|
EASL Studio Podcast: What is really new in the EASL CPG on ACLF?
|
Sep 07, 2023 |
|
EASL Studio Podcast: United we stand: Global societies collaborating to beat liver disease
|
Aug 18, 2023 |
|
EASL Studio Podcast: Practice changing highlights from EASL Congress 2023
|
Aug 17, 2023 |
|
EASL Studio Podcast: Steatotic liver disease global consensus to change nomenclature
|
Aug 17, 2023 |
|
EASL Studio Podcast: The battle to reduce alcohol harms… EASL’s new policy
|
Aug 17, 2023 |
|
EASL Studio Podcast: Highlights of liver cancer research at EASL Congress 2023
|
Aug 17, 2023 |
|
EASL Studio Podcast: EASL Congress 2023: Back to the future
|
Aug 17, 2023 |
|
EASL Studio Podcast: The conundrum of NASH: The growing global disease burden with low disease awareness
|
Jun 15, 2023 |
|
EASL Studio Podcast: JHEP Live: New and promising drugs for NASH on the horizon
|
Jun 08, 2023 |
|
EASL Studio Podcast: Why you should stop smoking if you love your liver
|
Jun 01, 2023 |
|
EASL Studio Podcast: COST Actions: Opportunities for pan-European collaborations in liver diseases
|
May 25, 2023 |
|
EASL Studio Podcast: Promoting Liver Health: An urgent call for action at WHO
|
May 24, 2023 |
|
EASL Studio Podcast: HDV: The devil becomes treatable
|
May 19, 2023 |
|
EASL Studio Podcast: Liver nurses in Europe: Are there enough and can they do more?
|
May 11, 2023 |
|
EASL Studio Podcast: Albumin in cirrhosis: For all, for some, for none
|
May 04, 2023 |
|
EASL Studio Podcast: Highlights from the EASL Liver Cancer Summit 2023
|
Apr 27, 2023 |
|
EASL Studio Podcast: Diagnostic and therapeutic challenges in Wilson’s disease
|
Apr 20, 2023 |
|
EASL Studio Podcast: A new strategy for liver cancer screening: EASL Policy Statement on risk-based surveillance
|
Apr 19, 2023 |
|
EASL Studio Podcast: EASL-EF CLIF and EU Grants: Exploring novel mechanism and treatment of chronic liver failure
|
Apr 13, 2023 |
|
EASL Studio Podcast: JHEP Live: Liver transplantation for alcohol-related hepatitis
|
Apr 06, 2023 |
|
EASL Studio Podcast: NAFLD and NASH – moving beyond the liver biopsy – where are we now?
|
Mar 30, 2023 |
|
EASL Studio Podcast: YI Choice: Gene therapy for liver disease — RNA interference and beyond
|
Mar 23, 2023 |
|
EASL Studio Podcast: Ascites: New solution for an old problem?
|
Mar 16, 2023 |
|
EASL Studio Podcast: YI Choice: Gender equality in academics — reducing the gap
|
Mar 09, 2023 |
|
EASL Studio Podcast: Alcohol and food policies
|
Mar 02, 2023 |
|
EASL Studio Podcast: Regenerating the liver graft with a machine?
|
Feb 16, 2023 |
|
EASL Studio Podcast: AI for Dummies
|
Feb 09, 2023 |
|
EASL Studio Podcast: JHEP Live: Is the term ‘decompensated cirrhosis’ outdated?
|
Feb 02, 2023 |
|
EASL Studio Podcast: A 360 approach to beat alcohol-related liver disease
|
Jan 26, 2023 |
|
EASL Studio Podcast: YI Choice: How to build consortia and registries
|
Jan 19, 2023 |
|
EASL Studio Podcast: Hepatitis B elimination: How far behind are we and what do we need to change to achieve it?
|
Jan 12, 2023 |
|
EASL Studio Podcast: Liver cancer in 2022: Wrap-up & outlook
|
Dec 22, 2022 |
|
EASL Studio Podcast: Chronic portal vein thrombosis: Anticoagulation and interventional radiology for all patients?
|
Dec 15, 2022 |
|
EASL Studio Podcast: The future of hepatology
|
Dec 08, 2022 |
|
EASL Studio Podcast: Next-generation metrics for science beyond Journal impact factor and citations: The role of social media
|
Dec 01, 2022 |
|
EASL Studio Podcast: Meeting the challenge of antimicrobial resistance (AMR) in cirrhosis: the invisible threat that lies within
|
Nov 24, 2022 |
|
EASL Studio Podcast: Regenerative Hepatology: From stem cells to tissue engineering
|
Nov 17, 2022 |
|
EASL Studio Podcast: JHEP Live: Antisense oligonucleotides vs. siRNAs in the treatment of chronic hepatitis B: Who will be the winner, if at all?
|
Nov 03, 2022 |
|
EASL Studio Podcast: Transplanting patients with cancer – Is there a limit?
|
Oct 31, 2022 |
|
EASL Studio Podcast: Bugs and the liver — The role of the gut microbiome in liver diseases
|
Oct 20, 2022 |
|
EASL Studio Podcast: How to improve end-of-life care in liver disease?
|
Oct 13, 2022 |
|
EASL Studio Podcast: JHEP Live: Stigma and alcohol
|
Oct 06, 2022 |
|
EASL Studio Podcast: Special Edition: Highlights of EASL NAFLD Summit 2022
|
Sep 29, 2022 |
|
EASL Studio Podcast: Liver transplantation for ACLF: Opportunities, challenges and pitfalls
|
Sep 15, 2022 |
|
EASL Studio Podcast: JHEP Live: Covid vaccination and associated autoimmune hepatitis
|
Sep 09, 2022 |
|
EASL Studio Podcast: Teatime - 23 June 2022
|
Jul 07, 2022 |
|
EASL Studio Podcast: Teatime - 25 June 2022
|
Jul 07, 2022 |
|
EASL Studio Podcast: Teatime - 24 June 2022
|
Jul 07, 2022 |
|
EASL Studio Podcast: Teatime - 22 June 2022
|
Jul 07, 2022 |
|
EASL Studio Podcast: Midday Talks on Improving Liver Cancer Care and Prevention - 23 June 2022
|
Jul 07, 2022 |
|
EASL Studio Podcast: How can our response to the climate crisis transform and improve hepatology services?
|
Jun 30, 2022 |
|
EASL Studio Podcast: EASL Haemochromatosis Guidelines 2022
|
Jun 16, 2022 |
|
EASL Studio Podcast: JHEP Live on the best animal model for HCC – Lost in translation?
|
Jun 02, 2022 |
|
EASL Studio Podcast : Digital Pathology
|
May 20, 2022 |
|
EASL Studio Podcast: Nurse and AHP Focus: Sustainable Hepatology – Insights in nursing initiatives
|
May 11, 2022 |
|
EASL Studio Podcast - YI Choice: Propelling liver cell biology into the third dimension
|
Apr 21, 2022 |
|
EASL Studio Podcast: Betablockers in cirrhosis: Has Baveno consensus gone too far?
|
Apr 05, 2022 |
|
EASL Studio Podcast: New era for science dissemination: The role of social media
|
Apr 05, 2022 |
|
EASL Studio Podcast: Should anticoagulants be given to patients with cirrhosis to improve outcome?
|
Apr 05, 2022 |
|
Liver Cancer
|
Mar 24, 2021 |
|
COVID-19 vaccination in patients with liver disease
|
Mar 17, 2021 |